Stock 90B SOPHIA GENETICS SA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SOPHiA GENETICS SA Deutsche Boerse AG

Equities

90B

CH1125843347

Real-time Estimate Tradegate
Other stock markets
 11:13:15 01/07/2024 BST 		5-day change 1st Jan Change
4.27 EUR +0.23% Intraday chart for SOPHiA GENETICS SA -3.23% -2.78%
06-27 Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target MT
06-24 Sophia Genetics S. A. Launches New Residual Acute Myeloid Application CI

Evolution of the average Target Price on SOPHiA GENETICS SA

Price target over the last 5 years

History of analyst recommendation changes

c2d78969061f9601fc1858fbb55b6.nIXhk4_OJKBGDF-lncm8ODTx8QsHgWlJhXm4OfRloNc.y7anpMaBbO0HNAfxzvGMdmyakExe1B4Z9BLadqxX14Oo9LbM6fxglz5Caw~38f39243d6ee9b5b6c06988ca4ba6aed

Analyst Recommendations on SOPHiA GENETICS SA

Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target MT
RBC Initiates SOPHiA GENETICS at Outperform With $8 Price Target, Notes 'Attractive' Entry Point, Exposure to Long-Term Growth in Sequencing, Life Science Research MT
Credit Suisse Raises SOPHiA GENETICS' Price Target to $5 From $2.25 After 'Solid' Q1 Results, Keeps Neutral Rating MT
Morgan Stanley Trims Price Target on Sophia Genetics to $10 From $11, Maintains Overweight Rating MT
Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $11 From $12, Maintains Overweight Rating MT
BTIG Starts SOPHiA GENETICS at Buy With $6 Price Target MT
Credit Suisse Starts SOPHiA GENETICS at Neutral With $2 Price Target MT
Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $12 From $13, Maintains Overweight Rating MT
JPMorgan Lowers Price Target for SOPHiA GENETICS SA to $18 From $23, Maintains Overweight Rating MT
Morgan Stanley Adjusts SOPHiA GENETICS' Price Target to $17 from $18, Keeps Overweight Rating MT
Morgan Stanley Adjusts SOPHiA GENETICS Price Target to $18 From $23, Maintains Overweight Rating MT
SOPHIA GENETICS : Credit Suisse Starts SOPHiA GENETICS at Outperform with $22 Price Target MT
SOPHIA GENETICS : Morgan Stanley Starts SOPHiA GENETICS at Overweight With $24 Price Target MT
SOPHIA GENETICS : JPMorgan Starts SOPHiA GENETICS at Overweight With $23 Price Target MT
SOPHIA GENETICS : Cowen Initiates Coverage on SOPHiA GENETICS SA With Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.58 USD
Average target price
8 USD
Spread / Average Target
+74.67%
High Price Target
10 USD
Spread / Highest target
+118.34%
Low Price Target
6 USD
Spread / Lowest Target
+31.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SOPHiA GENETICS SA

RBC Capital Markets
Morgan Stanley
Credit Suisse
BTIG
JPMorgan Chase
Cowen

Ratings for SOPHiA GENETICS SA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SOPH Stock
  4. 90B Stock
  5. Consensus SOPHiA GENETICS SA